Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Karla M Miller"'
Autor:
Robert Orr, Kenneth Sands, Russell E. Poland, Sarah K. Dutcher, Austin Cosgrove, Alfred Sorbello, Henry Francis, Noelle M. Cocoros, Karla M Miller, Greg Measer, Edward Rosen, Candace C. Fuller
Publikováno v:
Influenza and Other Respiratory Viruses. 16:265-275
Background We assessed the ability to identify key data relevant to influenza and other respiratory virus surveillance in a large-scale US-based hospital electronic medical record (EMR) dataset using seasonal influenza as a use case. We describe char
Autor:
Edward Murray, L. Hayley Burgess, Karla M Miller, Mandelin Cooper, Scott Harris, Joan S. Kramer, Elizabeth Wiggins
Publikováno v:
Journal of Pharmacy Practice. 35:184-189
As the COVID-19 pandemic swept through the United States, our heath-system mobilized clinical pharmacy services to address critical clinical medication management needs. Reinforcing recommended medication management strategies for clinical pharmacist
Autor:
Kimberly Korwek, Karla M Miller, Kenneth Sands, Richard P. Wenzel, Edmund Jackson, Jonathon D. Roach, Russell E. Poland, Jonathan B. Perlin, L. Hayley Burgess, Laura E McLean
Publikováno v:
Infection Control and Hospital Epidemiology
Infection Control & Hospital Epidemiology
Infection Control & Hospital Epidemiology
Objective:To determine risk factors for mortality among COVID-19 patients admitted to a system of community hospitals in the United States.Design:Retrospective analysis of patient data collected from the routine care of COVID-19 patients.Setting:Syst
Autor:
Kenneth Sands, Laura E McLean, Jonathon D. Roach, Richard P. Wenzel, L. Hayley Burgess, Kimberly Korwek, Jonathan B. Perlin, Karla M Miller, Russell E. Poland, Edmund Jackson
Publikováno v:
International Journal of Infectious Diseases
International Journal of Infectious Diseases, Vol 104, Iss, Pp 34-40 (2021)
International Journal of Infectious Diseases, Vol 104, Iss, Pp 34-40 (2021)
Highlights • Hydroxychloroquine was proposed as a treatment for COVID-19 in the early pandemic. • Data from 1669 COVID-19 patients in the United States was analyzed. • Hydroxychloroquine was associated with an increased risk of mortality.
Autor:
Joan S. Kramer, Karla M Miller, Christine Dunn, Brian Moran, Mandelin Cooper, L. Hayley Burgess, Edward Murray
Publikováno v:
HCA Healthcare Journal of Medicine. 1
Autor:
Jeffrey Guy, Karla M Miller, L. Hayley Burgess, Mandelin Cooper, Elizabeth Wiggins, Julia Moody, Theresa Baltz
Publikováno v:
HCA Healthcare Journal of Medicine. 1
Autor:
Lesley H. Curtis, Adee Kennedy, Heba Ismail, Candace C. Fuller, Margaret Johnson, Russell E. Poland, Vinod E. Nambudiri, Austin Cosgrove, Richard M. Kaufman, Karla M Miller, Kimberly Smith, Jason Hickok, Meghan A Baker, Robert Rosofsky, David J. Mohlman, Stacey Honda, Mayura Shinde, Salim Surani, Caren Spencer-Smith
Publikováno v:
Transfusion
INTRODUCTION Transfusion-related acute lung injury (TRALI), an adverse event occurring during or within 6 hours of transfusion, is a leading cause of transfusion-associated fatalities reported to the US Food and Drug Administration. There is limited
Autor:
Laura E McLean, Richard P. Wenzel, Kenneth Sands, Russell E. Poland, L. Hayley Burgess, Jonathon D. Roach, Kimberly Korwek, Karla M Miller, Edmund Jackson, Jonathan B. Perlin
Publikováno v:
Infection Control and Hospital Epidemiology
Infection Control & Hospital Epidemiology
Infection Control & Hospital Epidemiology
Coronavirus disease 2019 (COVID-19) has migrated to regions that were initially spared, and it is likely that different populations are currently at risk for illness. Herein, we present our observations of the change in characteristics and resource u
Publikováno v:
American Journal of Health-System Pharmacy
Autor:
Jane Englebright, Julia Moody, Karla M Miller, Mandelin Cooper, Edward Septimus, L. Hayley Burgess
Publikováno v:
American journal of infection control. 47(1)
Background Antimicrobial stewardship is recommended as a crucial mechanism to reduce the emergence of antimicrobial resistance. The purpose of this article was to describe implementation of antimicrobial management programs (AMPs) across a large heal